Correction to: Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro Xiaoyu YangYan WangMorteza Akbari Correction 07 July 2022 Article: 138
Questions to guide cancer evolution as a framework for furthering progress in cancer research and sustainable patient outcomes Jason A. SomarelliJames DeGregoriFrank H. Laukien Perspectives in Oncology Open access 04 July 2022 Article: 137
Metformin inhibits the development and metastasis of colorectal cancer Kiyoaki SugiuraKoji OkabayashiYuko Kitagawa Original Paper 02 July 2022 Article: 136
MORC2/β-catenin signaling axis promotes proliferation and migration of breast cancer cells Himanshu Singh SarohaRohith Kumar GuddetiSuresh B. Pakala Original Paper 21 June 2022 Article: 135
Secretome of senescent hepatoma cells modulate immune cell fate by macrophage polarization and neutrophil extracellular traps formation Bijoya SenSavera AggarwalGayatri Ramakrishna Original Paper 21 June 2022 Article: 134
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors Shazia SofiUmar MehrajManzoor Ahmad Mir Original Paper 20 June 2022 Article: 133
Identification of oncogenic signaling pathways associated with the dimorphic metabolic dysregulations in gastric cancer subtypes Karthik BalakrishnanKumaresan Ganesan Original Paper 20 June 2022 Article: 132
NK and cells with NK-like activities in cancer immunotherapy-clinical perspectives Keywan MortezaeeJamal Majidpoor Review Article 18 June 2022 Article: 131
The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies Hamed HosseinalizadehMehrdad MahmoodpourMehryar Habibi Roudkenar Review Article 18 June 2022 Article: 130
Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches D. J. McMahonJ. P. GleesonR. M. Bambury Review Article 18 June 2022 Article: 129
Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma Shiqi MiaoJing SongLongke Ran Original Paper 18 June 2022 Article: 128
The crosstalk between long non-coding RNAs and the hedgehog signaling pathway in cancer Marzieh Lotfian SargaziSaeideh Jafarinejad-FarsangiZahra Miri Karam Review Article 18 June 2022 Article: 127
Targeting UPR signaling pathway by dasatinib as a promising therapeutic approach in chronic myeloid leukemia Buket OzelSezgi KipcakNur Selvi Gunel Original Paper 18 June 2022 Article: 126
Inhibition of noncaspase proteases, calpain and proteasome, via ALLN and Bortezomib contributes to cell death through low degradation of pro-/anti-apoptotic proteins and apoptosis induction Roghaye HamidiFarangis AtaeiSaman Hosseinkhani Original Paper 18 June 2022 Article: 125
E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2 Qianfan LiuChunzhuo SongHaitao Zhu Original Paper 18 June 2022 Article: 124
Identification of prostate cancer subtypes based on immune signature scores in bulk and single-cell transcriptomes Canping ChenJiangti LuoXiaosheng Wang Original Paper 18 June 2022 Article: 123
Effects of folate-conjugated Fe2O3@Au core–shell nanoparticles on oxidative stress markers, DNA damage, and histopathological characteristics: evidence from in vitro and in vivo studies Habib GhaznaviMohammad Reza HajinezhadSaman Sargazi Original Paper 18 June 2022 Article: 122
Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapy J. Azevedo-SilvaD. Tavares-ValenteM. Casal Original Paper 18 June 2022 Article: 121
